Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Neurochem Res. 2018 Mar 14;44(1):234–246. doi: 10.1007/s11064-018-2502-2

Fig. 2:

Fig. 2:

HIV neurotoxins potentiate NMDARs to evoke distinct synaptic scaling and neuronal death pathways. GluN2A-containing NMDARs promote anti-apoptotic pathways and regulate changes to excitatory and inhibitory synapses. GluN2B-containing NMDARs promote pro-apoptotic pathways and prevent synapse recovery. Figure modified from [60].